Pfizer warns US about a shortage of coronavirus vaccine
Health
- 08 December, 2020
- 08:08
The US company Pfizer informed the Administration of President Donald Trump that it could not provide enough additional doses of the coronavirus vaccine until the end of June or July 2021, as other states have bought up most of the stocks. Report says, citing the Russian press.
According to the publication, this suggests that the US government probably will not increase Pfizer's vaccine supply as quickly as planned. It raises doubts about whether the country's authorities will be able to adhere to the schedule and vaccinate most citizens by the end of spring or early summer.
Earlier, the American giant Pfizer and the German company BioNTech applied for registration of their coronavirus vaccine in the European Union.
Latest News
11:08
Baku Marathon 2026 kicks off
Individual sports10:55
8 wagons of fertilizer to be sent to Armenia via Azerbaijan
Foreign policy10:32
Israeli security cabinet expected to discuss possible resumption of Gaza war
Other countries10:16
ADB VP: Without deep capital markets, CAREC potential remains limited
Finance10:00
US to reduce troops stationed abroad by more than 5,000 — Trump
Other countries09:43
59th annual meeting of ADB board of governors gets underway in Samarkand
Finance09:31
Embassy: Carlon's visit to Karabakh underscores growing US-Azerbaijan cooperation
Foreign policy09:17
Photo
Airblue launches Baku–Lahore flight
Infrastructure09:06